Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?

被引:36
作者
van Tuyl, Lilian H. D.
Plass, Anne Marie C.
Lems, Willem F.
Voskuyl, Alexandre E.
Dijkmans, Ben A. C.
Boers, Maarten
机构
[1] VU Univ Med ctr, Dept Clin Epidemiol & Biostat, NL-1053 MB Amsterdam, Netherlands
[2] Vu Univ Med Ctr, EMGo Inst, Amsterdam, Netherlands
[3] VU Univ Med Ctr, Dept Rheumatol, Amsterdam, Netherlands
关键词
D O I
10.1136/ard.2006.067447
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The Combinatietherapie Bij Reumatoide Artritis ( COBRA) trial has proved that combination therapy with prednisolone, methotrexate and sulphasalazine is superior to sulphasalazine monotherapy in suppressing disease activity and radiological progression of early rheumatoid arthritis ( RA). In addition, 5 years of follow- up proved that COBRA therapy results in sustained reduction of the rate of radiological progression. Despite this evidence, Dutch rheumatologists seem reluctant to prescribe COBRA therapy. Objective: To explore the reasons for the reluctance in Dutch rheumatologists to prescribe COBRA therapy. Methods: A short structured questionnaire based on social psychological theories of behaviour was sent to all Dutch rheumatologists ( n = 230). Results: The response rate was 50%. COBRA therapy was perceived as both effective and safe, but complex to administer. Furthermore, rheumatologists expressed their concern about the large number of pills that had to be taken, the side effects of high- dose prednisolone and the low dose of methotrexate. Although the average attitude towards the COBRA therapy was slightly positive ( above the neutral point), the majority of responding rheumatologists had a negative intention ( below the neutral point) to prescribe COBRA therapy in the near future. Conclusion: The reluctance of Dutch rheumatologists to prescribe effective COBRA therapy may be due to perceptions of complexity of the treatment schedule and negative patientrelated consequences of the therapy.
引用
收藏
页码:974 / 976
页数:3
相关论文
共 6 条
  • [1] Ajzen, 2005, ATTITUDES PERSONALIT
  • [2] Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
    Boers, M
    Verhoeven, AC
    Markusse, HM
    vandeLaar, MAFJ
    Westhovens, R
    vanDenderen, JC
    vanZeben, D
    Dijkmans, BAC
    Peeters, AJ
    Jacobs, P
    vandenBrink, HR
    Schouten, HJA
    vanderHeijde, DMFM
    Boonen, A
    vanderLinden, S
    [J]. LANCET, 1997, 350 (9074) : 309 - 318
  • [3] Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI 10.1002/art.23364
  • [4] Korthals-de Bos IBC, 2004, J RHEUMATOL, V31, P1709
  • [5] COBRA combination therapy in patients with early rheumatoid arthritis -: Long-term structural benefits of a brief intervention
    Landewé, RBM
    Boers, M
    Verhoeven, AC
    Westhovens, R
    van de Laar, MAFJ
    Markusse, HM
    van Denderen, JC
    Westedt, ML
    Peeters, AJ
    Dijkmans, BAC
    Jacobs, P
    Boonen, A
    van der Heijde, DMFM
    van der Linden, S
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (02): : 347 - 356
  • [6] Verhoeven AC, 1998, BRIT J RHEUMATOL, V37, P1102